ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $816,000 | – | 1,101,086 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 90,000 | $222,000 | 0.17% |
| EQUITEC SPECIALISTS, LLC | 21,820 | $54,000 | 0.02% |
| TFS CAPITAL LLC | 46,886 | $116,000 | 0.01% |
| Westend Capital Management, LLC | 1,000 | $3,000 | 0.00% |
| A.R.T. Advisors, LLC | 33,414 | $82,000 | 0.00% |
| Virtu KCG Holdings LLC | 31,765 | $78,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,080 | $35,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,115 | $2,754,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,489 | $374,000 | 0.00% |
| BlackRock Investment Management, LLC | 73,717 | $182,000 | 0.00% |